Peptide-based immunotherapy in lupus: Where are we now?

By sjmartinez • October 2, 2023

P Singh R, S Bischoff D, S Singh S, H Hahn B. Peptide-based immunotherapy in lupus: Where are we now? Rheumatol Immunol Res. 2023 Sep 27;4(3):139-149. doi: 10.2478/rir-2023-0020. PMID: 37781681; PMCID: PMC10538607.

Tags: chemokine, cytokine, Geriatrics, immune tolerance, immunotherapy, lupus, peptide, Publications, regulatory T cells, Rheumatology, Veterans Administration

Using electronic patient reported outcomes (ePROs) to improve supportive care in ambulatory oncology care: a CFIR-guided pre-implementation formative evaluation

Brauer ER, Bastani R, Cheng E, Lazaro S, Wong DJ, St John MA, Ganz PA. Using electronic patient reported outcomes (ePROs) to improve supportive care[...]

Characteristics of US Veterans Potentially Susceptible to SNAP Time Limits

Smith PD, Gonzalez F, Saliba D. Characteristics of US Veterans Potentially Susceptible to SNAP Time Limits. JAMA Health Forum. 2026 Jul 2;7(7):e262212. doi: 10.1001/jamahealthforum.2026.2212. PMID:[...]

Markers of compromised gut epithelial barrier integrity increase during the menopause transition

Shieh A, Epeldegui M, Karlamangla AS, Jones R, Pacifici R, Greendale GA. Markers of compromised gut epithelial barrier integrity increase during the menopause transition. J[...]